From my conversations $35 AUD will not get a look in for board approval so would have to be hostile. $35 US might get over the line. IMO these values will be reached organically anyway if PMS phase 3 trial is positive in 2 years or so which as I've said before I believe is highly likely.
IMO the buyback is simply in response to the recent windfall and is a reasonable use of excess capital although like most medium - large holders I personally would have preferred a dividend. JP is clearly as frustrated as any of us at the price action over the last 6-10 months despite the positive milestones NEU has met as highlighted by hottod et al recently.
I am convinced JP and co know exactly what they have under the bonnet and it isn't $35 AUD/share. AIMO.
- Forums
- ASX - By Stock
- Ann: Update - Notification of buy-back - NEU
NEU
neuren pharmaceuticals limited
Add to My Watchlist
6.69%
!
$14.20

From my conversations $35 AUD will not get a look in for board...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$14.20 |
Change
0.890(6.69%) |
Mkt cap ! $1.761B |
Open | High | Low | Value | Volume |
$13.50 | $14.26 | $12.96 | $9.111M | 655.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2000 | $14.17 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.23 | 3278 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2000 | 14.170 |
2 | 1626 | 14.160 |
1 | 1000 | 14.100 |
2 | 2963 | 14.030 |
3 | 2000 | 14.000 |
Price($) | Vol. | No. |
---|---|---|
14.230 | 3278 | 1 |
14.250 | 2027 | 3 |
14.260 | 2920 | 1 |
14.270 | 1191 | 1 |
14.300 | 1163 | 2 |
Last trade - 16.15pm 27/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online